
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Clinical TrialsHansoh’s HS-10374 Delivers Promising Phase 3 Results in Plaque Psoriasis
Health TidingsXenon Submits Azetukalner NDA for Focal Seizures; Pauses Psychiatry Trial Enrollment
Clinical TrialsLongeveron Laromestrocel Misses ELPIS II HLHS Endpoint
Clinical TrialsNX210c Phase 2 ALS Trial Shows Reduced Functional Decline
Clinical TrialsContineum’s JNJ-5120/PIPE-307 Misses Phase 2 MDD Endpoint
Clinical TrialsZidesamtinib Shows 94% Response Rate in ROS1-Positive NSCLC
Clinical TrialsSetmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic Obesity
Clinical TrialsBeeline’s Afimetoran Meets Phase 2 Endpoint in SLE
Clinical TrialsArlo-cel Shows Strong Results in Hard-to-Treat Multiple MyelomaOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala